COVID-19 PRIMER Trademark

Trademark Overview

On Friday, April 3, 2020, a trademark application was filed for COVID-19 PRIMER with the United States Patent and Trademark Office. The USPTO has given the COVID-19 PRIMER trademark a serial number of 88859620. The federal status of this trademark filing is REGISTERED as of Tuesday, November 30, 2021. This trademark is owned by Primer Technologies, Inc.. The COVID-19 PRIMER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a website that uses natural language processing algorithms to summarize information in the field of clinical research findings in the field of COVID-19; providing a website that provides links to clinical research findings in the field of COVID-19
covid-19 primer

General Information

Serial Number88859620
Word MarkCOVID-19 PRIMER
Filing DateFriday, April 3, 2020
Status700 - REGISTERED
Status DateTuesday, November 30, 2021
Registration Number6578167
Registration DateTuesday, November 30, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkCOVID-NINETEEN PRIMER; COVID- ONE NINE PRIMER
Disclaimer with Predetermined Text"COVID-19"
Goods and ServicesProviding a website that uses natural language processing algorithms to summarize information in the field of clinical research findings in the field of COVID-19; providing a website that provides links to clinical research findings in the field of COVID-19

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 10, 2020
Primary Code042
First Use Anywhere DateMonday, April 6, 2020
First Use In Commerce DateMonday, April 6, 2020

Trademark Owner History

Party NamePrimer Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NamePrimer Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 30, 2021REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, October 27, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 22, 2021ASSIGNED TO LIE
Thursday, October 21, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, October 15, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, October 14, 2021USE AMENDMENT ACCEPTED
Thursday, October 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 13, 2021AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, October 13, 2021USE AMENDMENT FILED
Tuesday, October 12, 2021TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 12, 2021NON-FINAL ACTION E-MAILED
Monday, April 12, 2021NON-FINAL ACTION WRITTEN
Saturday, April 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION WRITTEN
Monday, September 28, 2020ASSIGNED TO EXAMINER
Friday, April 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 7, 2020NEW APPLICATION ENTERED

Related Keywords

primer covid field research providing clinical findings website links provides summarize